Cargando…
Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort
BACKGROUND: Patients with systemic lupus erythematosus (SLE) are at risk of developing COVID-19 due to underlying immune abnormalities and regular use of immunosuppressant medications. We aimed to evaluate the presence of SARS-CoV-2 IgG antibodies in patients with SLE with or without previous COVID-...
Autores principales: | Saxena, Amit, Guttmann, Allison, Masson, Mala, Kim, Mimi Y, Haberman, Rebecca H, Castillo, Rochelle, Scher, Jose U, Deonaraine, Kristina K, Engel, Alexis J, Belmont, H Michael, Blazer, Ashira D, Buyon, Jill P, Fernandez-Ruiz, Ruth, Izmirly, Peter M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8159192/ https://www.ncbi.nlm.nih.gov/pubmed/34075358 http://dx.doi.org/10.1016/S2665-9913(21)00114-4 |
Ejemplares similares
-
Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE
por: Zaminski, Devyn, et al.
Publicado: (2023) -
Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City
por: Saxena, Amit, et al.
Publicado: (2022) -
Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)
por: Conklin, John, et al.
Publicado: (2022) -
Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study
por: Fernandez-Ruiz, Ruth, et al.
Publicado: (2020) -
3448 Macrophages, APOL1 Genotype, & Immunometabolism in CVD (MAGIC
por: Blazer, Ashira D., et al.
Publicado: (2019)